medical oncology


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to medical oncology: medical oncologist

medical oncology

A subspecialty of oncology which in the UK focuses on managing solid (non-haematologic) cancer—i.e., not lymphomas, leukaemias or myelomas—including carcinoma (adenocarcinoma, squamous cell, neuroendocrine, etc.), melanoma, sarcoma, glioma, teratoma, mesothelioma, etc.

Medical oncologists treat solid cancers with chemotherapy and other poisons, biological response modifiers and monoclonal antibodies. Where high-dose chemotherapy is appropriate, the patient’s depleted/damaged bone marrow is reconstituted with the patient’s own, previously stored stem cells.
References in periodicals archive ?
Merck Foundation will provide eight doctors from both Uganda and Tanzania with one -year medical oncology fellowship program.
The Medical Oncology Clinical Information System (MOCIS) Programme is an eHealth programme under the leadership of the National Cancer Control Programme (NCCP).
In 1981, he joined the staff of Dana-Farber, where he is chair of the department of medical oncology.
The symposium is part of the chain arranged by Medical Oncology
How does the inclusion of medical oncology VCC sites vary in their effect on the minimum travel time based on the type of location, that is, urban area, large rural city, small rural town, isolated rural town?
Medical Oncology support is the competitive advantage and key differentiator that drives DAVA's accrual enhancement performance.
Flatiron Health said it is also making continued investments into OncoEMR across infrastructure, interoperability and clinical workflow to ensure it remains the leading cloud-based medical oncology electronic health record.
NovaRx, a United States-based biopharmaceutical company, is presenting the results from the Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer at the European Society for Medical Oncology 2013 annual meeting, scheduled for tomorrow, September 28, in Amsterdam.
M2 PHARMA-September 27, 2013-NovaRx to present results from Phase III trial of Lucanix at European Society for Medical Oncology meeting(C)2013 M2 COMMUNICATIONS
Currently, Dr Radvanyi is an associate professor in the Department of Melanoma Medical Oncology Research at the University of Texas MD Anderson Cancer Center in Houston.

Full browser ?